Literature DB >> 16214168

The high-mobility group transcription factor Sox10 interacts with the N-myc-interacting protein Nmi.

Beate Schlierf1, Stefan Lang, Thomas Kosian, Torsten Werner, Michael Wegner.   

Abstract

The high-mobility group transcription factor Sox10 exerts many different roles during development of the neural crest and nervous system. To unravel its complex transcriptional functions, we have started to look for interaction partners. Here, we identify an association of Sox10 with the N-myc interactor Nmi, which was mediated by the high-mobility group of Sox10 and the central region of Nmi. In vivo relevance of this interaction is indicated by the fact that both proteins were co-expressed in glial cells, gliomas and in the spinal cord. Additionally, subcellular localization of Nmi in C6 glioma depended on the presence of Sox10 such that nuclear Nmi was more frequent in Sox10-expressing cells. Importantly, Nmi modulated the transcriptional activity of Sox10 in reporter gene assays. Nmi effects varied between different Sox10 target gene promoters, indicating that Nmi function in vivo may be promoter-specific.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214168     DOI: 10.1016/j.jmb.2005.09.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Interferon activates promoter of Nmi gene via interferon regulator factor-1.

Authors:  Xiao Xu; Keli Chai; Yuhang Chen; Yongquan Lin; Suzhen Zhang; Xin Li; Wentao Qiao; Juan Tan
Journal:  Mol Cell Biochem       Date:  2017-09-14       Impact factor: 3.396

2.  Genetic variants in N-myc (and STAT) interactor and susceptibility to glioma in a Chinese Han population.

Authors:  Delong Meng; Xiaoying Li; Shuo Zhang; Yingjie Zhao; Xiao Song; Yuanyuan Chen; Shiming Wang; Ying Mao; Hongyan Chen; Daru Lu
Journal:  Tumour Biol       Date:  2014-11-12

3.  N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm.

Authors:  Xiaomei Hu; Wei Yang; Ruikang Liu; Yunqi Geng; Wentao Qiao; Juan Tan
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

4.  N-Myc-Interacting Protein Negatively Regulates TNF-α-Induced NF-κB Transcriptional Activity by Sequestering NF-κB/p65 in the Cytoplasm.

Authors:  Jingjing Hou; Shihao Jiang; Jiabao Zhao; Dong Zhu; Xinmeng Zhao; Jian-Chun Cai; Si Qing Zhang
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

5.  High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.

Authors:  Delong Meng; Yuanyuan Chen; Dapeng Yun; Yingjie Zhao; Jingkun Wang; Tao Xu; Xiaoying Li; Yuqi Wang; Li Yuan; Ruochuan Sun; Xiao Song; Cong Huai; Lingna Hu; Song Yang; Taishan Min; Juxiang Chen; Hongyan Chen; Daru Lu
Journal:  Oncotarget       Date:  2015-03-10

6.  N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells.

Authors:  Brandon J Metge; Aparna Mitra; Dongquan Chen; Lalita A Shevde; Rajeev S Samant
Journal:  Sci Rep       Date:  2015-07-06       Impact factor: 4.379

7.  NMI and EMT.

Authors:  Rajeev S Samant; Lalita A Shevde
Journal:  Oncoscience       Date:  2014-06-19

Review 8.  Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination.

Authors:  Hawley C Pruitt; Daniel J Devine; Rajeev S Samant
Journal:  Int J Cancer       Date:  2016-03-11       Impact factor: 7.396

9.  The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors.

Authors:  Sandra Wissmüller; Thomas Kosian; Michael Wolf; Markus Finzsch; Michael Wegner
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

10.  microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.

Authors:  Jack W Rostas; Hawley C Pruitt; Brandon J Metge; Aparna Mitra; Sarah K Bailey; Sejong Bae; Karan P Singh; Daniel J Devine; Donna L Dyess; William O Richards; J Allan Tucker; Lalita A Shevde; Rajeev S Samant
Journal:  Mol Cancer       Date:  2014-08-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.